Vivien Wong

This profile gathers the share dealings of Vivien Wong across 2 companies, led by Cyclo Therapeutics, Inc. and Progenics Pharmaceuticals Inc. Over a trading history stretching from 19 June 2020 to 27 February 2025, the count stands at 7 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 3 March 2025 with a share grant in Cyclo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.